In addition, studies in human stromal cells in chronic lymphocytic leukaemia (CLL) showed that TBB inhibited CK2 and induced time- and dose-dependent cell death by apoptosis [57,82], which was accompanied by a reduction in PTEN and Akt phosphorylation [83]. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.